Clinical Trial Update: Safety and Efficacy of AMT-RegeneraActiva in the Management of Knee Osteoarthritis (OA) [NA]

View source ↗

Summary

A clinical trial evaluating AMT-RegeneraActiva for knee osteoarthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• AMT-RegeneraActiva

Snippet

Sponsor: Human Brain Wave S.r.l. | Conditions: Knee Osteoarthritis | NA | Status: WITHDRAWN